Sandostatin LAR Depot vs. Surgery for Treating Acromegaly

NCT00001860 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Acromegaly
Pituitary Neoplasm

Interventions

DRUG: Sandostatin LAR Depot versus transsphenoidal surgery

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)